MedTrace Logo

Effect of Morphine, Tramadol, and Ketorolac on Postoperative Stress and Immune Responses

NCT02449954 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-05-21

No results posted yet for this study

Summary

Comparison between the effects of intravenous morphine, tramadol and ketorolac on stress and immune responses in patients undergoing modified radical mastectomy

Conditions

Interventions

DRUG

Intravenous morphine sulphate

Group I:received IV 0.1mg/kg morphine sulphate.

DRUG

Intravenous tramadol HCL

Group II:received IV 2 mg/kg tramadol HCL.

DRUG

Intravenous ketorolac tromethamine

Group III: received IV 30 mg ketorolac tromethamine

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-04-30
Completion
2015-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02449954 on ClinicalTrials.gov